Enabling better biologics
An innovator in developing therapeutic antibodies and fusion proteins
0
+
employees
0
R&D platforms on therapeutic antibodies
0
projects in the pipeline
0
patents worldwide
0
+m²
R&D and CMC facilities
An innovator in developing therapeutic antibodies and fusion proteins
0
+
employees
0
R&D platforms on therapeutic antibodies
0
projects in the pipeline
0
patents worldwide
0
+m²
R&D and CMC facilities
Technology
Innovating for more efficient treatment of cancers and autoimmune diseases
Pipeline
Pressing forward to combat cancers
We have developed an innovative and differentiated pipeline of biologics, with projects ranging from preclinical through CMC stages.
Careers
Moving forward together
Talent development is part of our long-term priority and corporate responsibility.
Fapon Biopharma Announces a Safer Immunotherapy for Cancers
2024-06-04
Fapon and Stanford Healthcare Innovation Lab Co-Host Virtual Conference on RNA Delivery and Gene Editing Featuring Nobel Prize Winner
2024-03-25
Fapon Shares its Visionary Strategies at the Inaugural Innovative Diagnostics and Therapeutics Forum
2023-10-18
+86 769 86088555, Ext. 8018
biopharma@fapon.com
3F–4F, Building 10, Dongguan–Taiwan Bio-Tech Collaborative Incubation Center, 1 Taoyuan Road, Dongguan, Guangdong Province, China
Scan and follow Fapon LinkedIn Page
© Guangdong Fapon Biopharma Inc. All rights reserved.
Guangdong ICP No. 2024177910-1Links: